Slowing Alzheimer’s with Amyloid-Clearing Infusions

Slowing Alzheimer’s with Amyloid-Clearing Infusions

June is Brain Awareness Month, and in this episode of Sage Infusion Deep Dive, we explore a groundbreaking advancement in Alzheimer’s care: amyloid-clearing infusion therapies. Learn how newer treatments such as Kisunla and Leqembi are helping slow cognitive decline in people with early-stage Alzheimer’s disease by targeting amyloid plaque buildup in the brain. We discuss who may be eligible for these therapies, the importance of early diagnosis, what patients can expect during treatment, and why MRI monitoring plays a critical role in safety. You'll also hear how Sage Infusion’s MemoryWorkx program helps patients and families navigate referrals, scheduling, insurance, and ongoing support throughout the treatment journey. Join us as we examine how these innovative therapies are changing the future of Alzheimer’s care and offering new hope for patients and their loved ones. This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast. Sage Infusion content used to generate podcast:https://sageinfusion.com/2026/06/01/spotting-alzheimers-early-signs-symptoms-and-new-hope/ [https://sageinfusion.com/2026/06/01/spotting-alzheimers-early-signs-symptoms-and-new-hope/] https://sageinfusion.com/2026/05/29/aria-safety-tips/ [https://sageinfusion.com/2026/05/29/aria-safety-tips/]

Navigating Lupus & Advanced Therapies

In honor of World Lupus Day on May 10, this episode of Deep Dive explores the complexities of lupus—a chronic autoimmune disease often called the "invisible illness". We break down the latest information on specialized treatments and practical safety tips for those managing the condition.Join us as we discuss how medical breakthroughs and dedicated care teams are bringing renewed hope to the lupus community. This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast. Sage Infusion content used to generate podcast:

Targeted Relief For Reclaiming Your Mobility

In this episode of Sage Infusion Deep Dive, we explore how innovative treatments are helping patients overcome one of the biggest barriers to better health: chronic pain. In recognition of National Walking Day and National Move More Month, we discuss the powerful connection between pain management and mobility—and why movement is essential for overall well-being. The conversation highlights Qutenza®, a high-strength capsaicin patch designed to target nerve pain caused by conditions like diabetic peripheral neuropathy and postherpetic neuralgia. By working directly at the source of pain and providing relief for up to three months, this treatment is helping patients regain comfort, reduce reliance on oral medications, and get back to daily activities like walking. We also take a broader look at Sage Infusion’s comprehensive approach to care, including infusion therapies for rheumatoid arthritis and osteoporosis. These treatments not only reduce inflammation and strengthen bones but also empower patients to stay active, independent, and engaged in life. Ultimately, this episode is about more than treatment—it’s about restoring confidence, improving quality of life, and making movement possible again. This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast. Sage Infusion content used to generate podcast: https://sageinfusion.com/2026/03/30/nerve-pain-treatment-tips/ [https://sageinfusion.com/2026/03/30/nerve-pain-treatment-tips/]

Why Staying on Your IBD Medication Matters

In this episode of Sage Infusion Deep Dive, we focus on digestive health in recognition of National Colon Cancer Awareness Month and explore a critical message for patients living with Crohn’s disease and ulcerative colitis: controlling inflammation today protects your future health. Chronic inflammation from IBD doesn’t just cause uncomfortable symptoms — over time, it can increase the risk of serious complications, including colon cancer. We break down how advanced biologic therapies like Remicade, Entyvio, Skyrizi, Tremfya, and Stelara help calm the immune system, promote healing of the bowel lining, and reduce long-term cancer risk. We also discuss why staying on schedule with your infusions matters, the dangers of skipping doses, and how infusion therapy combined with routine colonoscopy surveillance creates a powerful prevention strategy. If you’re receiving IBD treatment — or supporting someone who is — this episode explains why feeling better isn’t the finish line. True disease control means protecting your colon for the long haul. This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast. Sage Infusion content used to generate podcast: https://sageinfusion.com/2026/02/24/why-staying-on-your-ibd-medication-matters/ https://sageinfusion.com/2026/03/01/controlling-inflammation-to-reduce-colon-cancer-risk-in-ibd/

Alpha-1 & Prolastin Explained

In this episode of Sage Infusion Deep Dive, we recognize Rare Disease Day by focusing on Alpha-1 Antitrypsin Deficiency—a genetic condition that can lead to serious lung damage and is often underdiagnosed. We break down how Prolastin infusion therapy works to replace the missing AAT protein, helping protect the lungs and slow disease progression. You’ll also learn what to expect during weekly infusions, potential side effects, and the lifestyle choices—like avoiding smoke, staying vaccinated, and keeping regular appointments—that support better outcomes. Plus, we discuss why family testing matters and how infusion centers play a vital role in delivering safe, supportive care for patients living with Alpha-1. This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast. Sage Infusion content used to generate podcast: https://sageinfusion.com/2026/02/09/rare-disease-day-shining-a-light-on-alpha-1-antitrypsin-deficiency/ [https://sageinfusion.com/2026/02/09/rare-disease-day-shining-a-light-on-alpha-1-antitrypsin-deficiency/] https://sageinfusion.com/2026/02/04/managing-alpha-1-antitrypsin-deficiency-with-prolastin/